Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 25Gastrointestinal 7Gynecologic 5Thoracic 4Tumor-Agnostic 3Other hematologic neoplasm 3CNS 3Sarcoma 2Other 2Lymphoid 2Head & Neck 2Genitourinary 2Endocrine 2Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Yoga × Genitourinary × Clear all
NCT03220945 2024-06-25

Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer

Emory University

Phase NA Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT02620033 2022-01-20

Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy

The University of Texas Health Science Center at San Antonio

Phase NA Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡